|
Review of the Relevant Data
|
| 14:10 |
Overview of the Goff Study (US)
Dr. M. Robyn Andersen (Fred Hutchinson Cancer Research Center, Seattle, USA) |
14:25
|
Overview of studies in progress
Dr Usha Menon, Anita Lim (University College London, UK)
|
| 14:40 |
Psychological studies relevant to ovarian cancer
Prof Lesley Fallowfield (University of Sussex, UK) |
| 14:55 |
Systematic review of literature relating to ovarian cancer signs and symptoms
Prof. Sean Kehoe (Oxford Radcliffe, UK)
|
| |
A Spectrum of Opinions (5 minutes each) |
| 15:30 |
The Ovacome/Patient Perspective
Louise Bayne (Ovacome) |
| 15:35 |
The Ovarian Cancer Action Perspective
Philippa Carr (Ovarian Cancer Action, UK)
|
| 15:40 |
The Wellbeing of Women Perspective
Gemma Hobson (Wellbeing of Women, UK) |
| 15:45 |
The Screening Perspective
Prof. Ian Jacobs (University College London and Institute for Women’s Health, UK) |
| 15:50 |
The British Gynaecological Cancer Society Perspective
Prof. David Luesley (Pan-Birmingham Gynaecological Cancer Centre)
|
| 15:55 |
The Primary Care Perspective
Dr Sarah Jarvis (Royal College of General Practitioners, UK) |
| 16:00 |
The Radiology Perspective
Dr. Jo McHugo (Birmingham Women’s Healthcare Trust/Royal College of Radiologists, UK) |
| 16:05 |
The Public Health Perspective
Prof. Peter Sasieni (Cancer Research UK)
|
